This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by von Segesser, L. K Articles by Corno, A Search for Related Content PubMed PubMed Citation Articles by von Segesser, L. K Articles by Corno, A Social Bookmarking                   What's this?

Alternatives to unfractioned heparin for anticoagulation in cardiopulmonary bypass

Department of Cardiovascular Surgery, CHUV, Centre Hospitalier Universitaire Vaudois, Lausanne, Ludwig.von_Segesser{at}chuv.hospvd.ch

X Mueller

Department of Cardiovascular Surgery, CHUV, Centre Hospitalier Universitaire Vaudois, Lausanne

B Marty

Department of Cardiovascular Surgery, CHUV, Centre Hospitalier Universitaire Vaudois, Lausanne

J Horisberger

Department of Cardiovascular Surgery, CHUV, Centre Hospitalier Universitaire Vaudois, Lausanne

A Corno

Department of Cardiovascular Surgery, CHUV, Centre Hospitalier Universitaire Vaudois, Lausanne

Despite the progress made in the development of cardiopulmonary bypass (CPB) equipment, systemic anticoagulation with unfractioned heparin and post-bypass neutralization with protamine are still used in most perfusion procedures. However, there are a number of situations where unfractioned heparin, protamine or both cannot be used for various reasons. Intolerance of protamine can be addressed with extracorporeal heparin removal devices, perfusion with (no) low systemic heparinization and, to some degree, by perfusion with alternative anticoagulants. Various alternative anticoagulation regimens have been used in cases of intolerance to unfractioned heparin, including extreme hemodilution, low molecular weight heparins, danaparoid, ancrod, r-hirudin, abciximab, tirofiban, argatoban and others.

In the presence of heparin-induced thrombocytopenia (HIT) and thrombosis, the use of r-hirudin appears to be an acceptable solution which has been well studied. The main issue with r-hirudin is the difficulty in monitoring its activity during CPB, despite the fact that ecarin coagulation time assessment is now available.

A more recent approach is based on selective blockage of platelet aggregation by means of monoclonal antibodies directed to GPIIb/IIIa receptors (abciximab) or the use of a GPIIb/IIIa inhibitor (tirofiban). An 80% blockage of the GPIIb/IIIa receptors and suppression of platelet aggregation to less than 20% allows the giving of unfractioned heparin and running CPB in a standard fashion despite HIT and thrombosis. Likewise, at the end of the procedure, unfractioned heparin is neutralized with protamine as usual and donor platelets are transfused if necessary. GPIIb/IIIa inhibitors are frequently used in interventional cardiology and, therefore, are available in most hospitals.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				N. Jagannathan Vegan? Sorry, we have porcine heparin on the menu! Anesth. Analg., March 1, 2006; 102(3): 976 - 976. [Full Text] [PDF]

				G. R. Manecke Jr, W. C. Wilson, W. R. Auger, and S. W. Jamieson Chronic Thromboembolic Pulmonary Hypertension and Pulmonary Thromboendarterectomy Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 2005; 9(3): 189 - 204. [Abstract] [PDF]

				C. S. Carr, A. Rayner, J. Ponte, and J. B. Desai Off-Pump Coronary Artery Bypass Grafting in a Heparin-Induced Thrombocytopenia Type II Patient Using Hirudin Ann. Thorac. Surg., February 1, 2005; 79(2): 696 - 698. [Abstract] [Full Text] [PDF]

				J. L. Francis, G. J. Palmer III, R. Moroose, and A. Drexler Comparison of bovine and porcine heparin in heparin antibody formation after cardiac surgery Ann. Thorac. Surg., January 1, 2003; 75(1): 17 - 22. [Abstract] [Full Text] [PDF]